Karthikeyan Kesavan

About

Dr. K. Kesavan, an accomplished pharmaceutical scientist with a Ph.D. in Pharmaceutics from IIT (BHU) and postdoctoral training at the University of Iowa, USA under the DBT-IUSSTF GETin Fellowship, specializes in nanopharmaceuticals and ocular drug delivery. Currently an Associate Professor at Guru Ghasidas Vishwavidyalaya, he brings over two decades of experience in developing mucoadhesive and cationic nanocarriers for sustained drug and gene delivery, contributing over 35 international publications, book chapters, and patents. His innovations include TPGS-Chitosan micelles for glaucoma and microemulsions for fungal keratitis. A mentor to numerous research students, he is a frequent speaker at global forums like Phar-East, Singapore and AIIMS Raipur, and has organized national workshops on nanocarriers. Recognized with awards such as Best Paper at nanoscience conferences and IQAC-GGV honors, Dr. Kesavan remains a key figure in advancing translational nanotechnology for improved ocular therapies.

Employment

• Guru Ghasidas University Associate Professor
  2024 - Present

Education

Education history is unavailable.

Projects & Funding

Projects & funding information is unavailable.

Publications (33)

• Stearylamine-Coated Cationic Phyto-Microemulsions Enhance Resveratrol Ocular Delivery for Glaucoma Therapy: Experimental and Preclinical Insights
  AAPS PharmSciTech 2026 DOI: 10.1208/s12249-026-03340-7
  +Save
• Forskolin in modern therapeutics: Pharmacology, disease targets, and drug delivery innovations
  Pharmacological Research - Natural Products 2026 DOI: 10.1016/j.prenap.2026.100599
  +Save
• Recent progress in immunotherapy and vaccine development for breast malignancies
  Advancements in the Treatment and Prevention of Breast Cancer 2026 DOI: 10.1016/b978-0-443-33653-9.00010-7
  +Save
• Nanocrystal Technologies: Concepts, Fundamentals, and Strategies
  Nanocrystal Technologies in Biomedical Sciences 2026 DOI: 10.1007/978-981-95-2968-1_1
  +Save
• Epigenetic modifications and therapies of gliomas: a precision medicine perspective
  Chemoresistance in Glioblastoma 2026 DOI: 10.1016/b978-0-443-33910-3.00004-2
  +Save
• Healing efficiency of nystatin-loaded chitosan-guar gum-based nanocapsules in experimental fungal keratitis
  International Journal of Biological Macromolecules 2025 DOI: 10.1016/j.ijbiomac.2025.146979
  +Save
• Tear-Driven Phase Transition Microemulsion for Ocular Delivery of Dexamethasone in the Effective Treatment of Uveitis
  Current Eye Research 2025 DOI: 10.1080/02713683.2025.2469243
  +Save
• Cationic nanocapsules as a non-viral vector for CRISPR-Cas9–based genome editing for myocilin associated glaucoma therapy
  AIMS Molecular Science 2025 DOI: 10.3934/molsci.2025020
  +Save
• Cationic Microemulsion of Voriconazole for the Treatment of Fungal Keratitis: In Vitro and In Vivo Evaluation
  Therapeutic Delivery 2024 DOI: 10.4155/tde-2023-0069
  +Save
• TPGS-chitosan conjugated mucoadhesive micelles of brinzolamide for glaucoma therapy: In vitro and in vivo evaluation
  Materialia 2023 DOI: 10.1016/j.mtla.2023.101711
  +Save